201 related articles for article (PubMed ID: 19717262)
1. Central nervous system Aspergillus infection after epidural analgesia: diagnosis, therapeutic challenges, and literature review.
Genzen JR; Kenney B
Diagn Microbiol Infect Dis; 2009 Nov; 65(3):312-8. PubMed ID: 19717262
[TBL] [Abstract][Full Text] [Related]
2. Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
Hoenigl M; Krause R
Curr Pharm Des; 2013; 19(20):3648-68. PubMed ID: 23278539
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
Clemons KV; Parmar R; Martinez M; Stevens DA
J Antimicrob Chemother; 2006 Aug; 58(2):466-9. PubMed ID: 16760192
[TBL] [Abstract][Full Text] [Related]
4. Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report.
Le TH; Kumar V; Gondal K; Barnes M; Siddique H; Buttar B; Kaell A
BMC Infect Dis; 2020 Feb; 20(1):175. PubMed ID: 32093604
[TBL] [Abstract][Full Text] [Related]
5. Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry.
Horn D; Sae-Tia S; Neofytos D
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):384-7. PubMed ID: 19249181
[TBL] [Abstract][Full Text] [Related]
6. A case of dual infection in a paediatric trauma victim of primary cutaneous aspergillosis caused by Aspergillus flavus and Aspergillus terreus.
Tak V; Mathur P; Xess I; Kale P; Sagar S; Misra MC
Indian J Med Microbiol; 2013; 31(2):193-6. PubMed ID: 23867682
[TBL] [Abstract][Full Text] [Related]
7. Aspergillosis infection over 20 years: a case report of probable vascular invasion in central nervous system.
Zhang Y; Wu X; Hu YP
BMC Neurol; 2020 Sep; 20(1):342. PubMed ID: 32917165
[TBL] [Abstract][Full Text] [Related]
8. Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.
Machetti M; Zotti M; Veroni L; Mordini N; Van Lint MT; Bacigalupo A; Paola D; Viscoli C
Transpl Infect Dis; 2000 Sep; 2(3):140-4. PubMed ID: 11429025
[TBL] [Abstract][Full Text] [Related]
9. Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era.
Guinea J; Recio S; Peláez T; Torres-Narbona M; Bouza E
Antimicrob Agents Chemother; 2008 Sep; 52(9):3444-6. PubMed ID: 18606840
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.
Schwartz S; Milatovic D; Thiel E
Br J Haematol; 1997 Jun; 97(3):663-5. PubMed ID: 9207418
[TBL] [Abstract][Full Text] [Related]
11. Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Howell A; Midturi J; Sierra-Hoffman M; Carpenter J; Hurley D; Winn R
Med Mycol; 2005 Nov; 43(7):651-5. PubMed ID: 16396251
[TBL] [Abstract][Full Text] [Related]
12. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
Verweij PE; Weemaes CM; Curfs JH; Bretagne S; Meis JF
J Clin Microbiol; 2000 Oct; 38(10):3900-1. PubMed ID: 11015433
[TBL] [Abstract][Full Text] [Related]
13. [Aspergillus bronchitis and aspergilloma treated successfully with voriconazole].
Freymond N; Le Loch JB; Devouassoux G; Harf R; Rakotomalala A; Pacheco Y
Rev Mal Respir; 2005 Nov; 22(5 Pt 1):811-4. PubMed ID: 16272984
[TBL] [Abstract][Full Text] [Related]
14. Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
de Sévaux RG; Kullberg BJ; Verweij PE; van de Nes JA; Meis JF; van der Meer JW
Clin Infect Dis; 1998 Apr; 26(4):996-7. PubMed ID: 9564492
[No Abstract] [Full Text] [Related]
15. Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Bonatti H; Lass-Floerl C; Angerer K; Singh N; Lechner M; Stelzmueller I; Singh R; Schmid T; Geltner C
Mycoses; 2010 Sep; 53(5):448-54. PubMed ID: 19496935
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.
Schwartz S; Reisman A; Troke PF
Infection; 2011 Jun; 39(3):201-10. PubMed ID: 21512792
[TBL] [Abstract][Full Text] [Related]
17. Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
Stern JB; Girard P; Caliandro R
Antimicrob Agents Chemother; 2004 Mar; 48(3):1065. PubMed ID: 14982812
[No Abstract] [Full Text] [Related]
18. Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis.
Mehta H; Mehta HB; Garg P; Kodial H
Indian J Ophthalmol; 2008; 56(3):243-5. PubMed ID: 18417831
[TBL] [Abstract][Full Text] [Related]
19. Anidulafungin treatment of candidal central nervous system infection in a murine model.
Kang CI; Rouse MS; Mandrekar JN; Steckelberg JM; Patel R
Antimicrob Agents Chemother; 2009 Aug; 53(8):3576-8. PubMed ID: 19506064
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report.
Hashemi SB; Shishegar M; Nikeghbalian S; Salahi H; Bahador A; Kazemi K; Dehghani M; Kakaei F; Gholami S; Janghorban P; Malek-Hosseini SA
Transplant Proc; 2009 Sep; 41(7):2933-5. PubMed ID: 19765479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
